Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

173 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Tests by US Infectious Disease Physicians: Results of an Emerging Infections Network Survey, March 2022.
Gundlapalli AV, Beekmann SE, Jones JM, Thornburg NJ, Clarke KEN, Uyeki TM, Satheshkumar PS, Carroll DS, Plumb ID, Briggs-Hagen M, Santibañez S, David-Ferdon C, Polgreen PM, McDonald LC. Gundlapalli AV, et al. Open Forum Infect Dis. 2023 Feb 18;10(3):ofad091. doi: 10.1093/ofid/ofad091. eCollection 2023 Mar. Open Forum Infect Dis. 2023. PMID: 36949879 Free PMC article.
Estimated SARS-CoV-2 antibody seroprevalence trends and relationship to reported case prevalence from a repeated, cross-sectional study in the 50 states and the District of Columbia, United States-October 25, 2020-February 26, 2022.
Wiegand RE, Deng Y, Deng X, Lee A, Meyer WA 3rd, Letovsky S, Charles MD, Gundlapalli AV, MacNeil A, Hall AJ, Thornburg NJ, Jones J, Iachan R, Clarke KEN. Wiegand RE, et al. Among authors: gundlapalli av. Lancet Reg Health Am. 2023 Feb;18:100403. doi: 10.1016/j.lana.2022.100403. Epub 2022 Dec 2. Lancet Reg Health Am. 2023. PMID: 36479424 Free PMC article.
Who Gets Sick From COVID-19? Sociodemographic Correlates of Severe Adult Health Outcomes During Alpha- and Delta-Variant Predominant Periods: September 2020-November 2021.
Wei SC, Freeman D, Himschoot A, Clarke KEN, Van Dyke ME, Adjemian J, Ahmad FB, Benoit TJ, Berney K, Gundlapalli AV, Hall AJ, Havers F, Henley SJ, Hilton C, Johns D, Opsomer JD, Pham HT, Stuckey MJ, Taylor CA, Jones JM. Wei SC, et al. Among authors: gundlapalli av. J Infect Dis. 2024 Jan 12;229(1):122-132. doi: 10.1093/infdis/jiad357. J Infect Dis. 2024. PMID: 37615368
Monoclonal Antibodies as SARS-CoV-2 Serology Standards: Experimental Validation and Broader Implications for Correlates of Protection.
Wang L, Patrone PN, Kearsley AJ, Izac JR, Gaigalas AK, Prostko JC, Kwon HJ, Tang W, Kosikova M, Xie H, Tian L, Elsheikh EB, Kwee EJ, Kemp T, Jochum S, Thornburg N, McDonald LC, Gundlapalli AV, Lin-Gibson S. Wang L, et al. Among authors: gundlapalli av. Int J Mol Sci. 2023 Oct 28;24(21):15705. doi: 10.3390/ijms242115705. Int J Mol Sci. 2023. PMID: 37958688 Free PMC article.
Surveillance for Emerging and Reemerging Pathogens Using Pathogen Agnostic Metagenomic Sequencing in the United States: A Critical Role for Federal Government Agencies.
Downie DL, Rao P, David-Ferdon C, Courtney S, Lee JS, Quiner C, MacDonald PDM, Barnes K, Fisher S, Andreadis JL, Chaitram J, Mauldin MR, Salerno RM, Schiffer J, Gundlapalli AV. Downie DL, et al. Among authors: gundlapalli av. Health Secur. 2024 Mar-Apr;22(2):85-92. doi: 10.1089/hs.2023.0099. Epub 2024 Apr 4. Health Secur. 2024. PMID: 38574329 Free PMC article.
Literature Review of Pathogen Agnostic Molecular Testing of Clinical Specimens From Difficult-to-Diagnose Patients: Implications for Public Health.
Downie DL, Rao P, David-Ferdon C, Courtney S, Lee JS, Kugley S, MacDonald PDM, Barnes K, Fisher S, Andreadis JL, Chaitram J, Mauldin MR, Salerno RM, Schiffer J, Gundlapalli AV. Downie DL, et al. Among authors: gundlapalli av. Health Secur. 2024 Mar-Apr;22(2):93-107. doi: 10.1089/hs.2023.0100. Epub 2024 Apr 12. Health Secur. 2024. PMID: 38608237 Free PMC article. Review.
Association between SARS-CoV-2 infection and select symptoms and conditions 31 to 150 days after testing among children and adults.
Zhang Y, Romieu-Hernandez A, Boehmer TK, Azziz-Baumgartner E, Carton TW, Gundlapalli AV, Fearrington J, Nagavedu K, Dea K, Moyneur E, Cowell LG, Kaushal R, Mayer KH, Puro J, Rasmussen SA, Thacker D, Weiner MG, Saydah S, Block JP; PCORnet Network Partners. Zhang Y, et al. Among authors: gundlapalli av. BMC Infect Dis. 2024 Feb 10;24(1):181. doi: 10.1186/s12879-024-09076-8. BMC Infect Dis. 2024. PMID: 38341566 Free PMC article.
Association between SARS-CoV-2 Infection and Select Symptoms and Conditions 31 to 150 Days After Testing among Children and Adults.
Zhang Y, Romieu-Hernandez A, Boehmer TK, Azziz-Baumgartner E, Carton TW, Gundlapalli AV, Fearrington J, Nagavedu K, Dea K, Moyneur E, Cowell LG, Kaushal R, Mayer KH, Puro J, Rasmussen SA, Thacker D, Weiner MG, Saydeh S, Block JP; PCORnet Network Partners. Zhang Y, et al. Among authors: gundlapalli av. medRxiv [Preprint]. 2022 Dec 19:2022.12.18.22283646. doi: 10.1101/2022.12.18.22283646. medRxiv. 2022. Update in: BMC Infect Dis. 2024 Feb 10;24(1):181. doi: 10.1186/s12879-024-09076-8. PMID: 36597540 Free PMC article. Updated. Preprint.
Relative Effectiveness of Coronavirus Disease 2019 Vaccination and Booster Dose Combinations Among 18.9 Million Vaccinated Adults During the Early Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Period-United States, 1 January 2022 to 31 March 2022.
Kompaniyets L, Wiegand RE, Oyalowo AC, Bull-Otterson L, Egwuogu H, Thompson T, Kahihikolo K, Moore L, Jones-Jack N, El Kalach R, Srinivasan A, Messer A, Pilishvili T, Harris AM, Gundlapalli AV, Link-Gelles R, Boehmer TK. Kompaniyets L, et al. Among authors: gundlapalli av. Clin Infect Dis. 2023 May 24;76(10):1753-1760. doi: 10.1093/cid/ciad063. Clin Infect Dis. 2023. PMID: 36750643 Free PMC article.
173 results